Cargando…
Homocysteine-Lowering Interventions in Chronic Kidney Disease
The incidence of cardiovascular events and mortality is higher in patients with chronic kidney disease (CKD) compared to the general population. Homocysteine (Hcy) appears to be an independent risk factor for cardiovascular diseases in general populations and patients with CKD. Further, hyperhomocys...
Autores principales: | Badri, Shirinsadat, Vahdat, Sahar, Seirafian, Shiva, Pourfarzam, Morteza, Gholipur-Shahraki, Tahereh, Ataei, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809459/ https://www.ncbi.nlm.nih.gov/pubmed/35198504 http://dx.doi.org/10.4103/jrpp.jrpp_75_21 |
Ejemplares similares
-
Effect of Omega-3 Fatty Acids Supplementation on Homocysteine Level in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
por: Gholipur-Shahraki, Tahereh, et al.
Publicado: (2022) -
Potential Benefits of Selenium Supplementation in Patients with Kidney Disease
por: Badri, Shirinsadat, et al.
Publicado: (2022) -
Potential of Drug Interactions as a Cause of Adverse Drug Reactions in Patients with Kidney Diseases
por: Shahraki, Tahereh Gholipur, et al.
Publicado: (2020) -
Effect of Selenium Supplementation on Lipid Profile, Anemia, and Inflammation Indices in Hemodialysis Patients
por: Assarzadeh, Samaneh, et al.
Publicado: (2023) -
Effects of Carnitine on Nutritional Parameters in Patients with Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis
por: Gholipur-Shahraki, Tahereh, et al.
Publicado: (2018)